Insulin pump therapy in childhood diabetes—cost implications for Primary Care Trusts

Feltbower, RG; Campbell, Fiona; Bodansky, H. J.; Stephenson, C.; McKinney, Patricia A.

doi:10.1111/j.1464-5491.2005.01763.x

Cited by 14 publications

(10 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the light of the initial CSII HTA and NICE guidance, Feltbower et al (2006) 242 analysed the Yorkshire Register of Diabetes in Children and Young Adults. This showed an annual incidence of T1DM under 15 years of age of 19 per 100,000 person-years.…”

Section: Costs Of Csii Versus MDImentioning

confidence: 99%

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

Cummins

Royle²,

Snaith³

et al. 2010

Health Technol Assess

184

155

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address. Paying by credit cardYou can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume. How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeT he Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of project...

show abstract

Section: Costs Of Csii Versus MDImentioning

confidence: 99%

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

Cummins

Royle²,

Snaith³

et al. 2010

Health Technol Assess

184

155

View full text Add to dashboard Cite

show abstract

“…n recent years, there has been a trend toward more intensive insulin regimens using multiple daily injections and pump therapy for children and young adults with type 1 diabetes (1)(2)(3). This trend should improve long-term glucose control, help avoid the chronic complications of diabetes, and, in theory, reduce mortality rates in subjects with type 1 diabetes.…”

mentioning

confidence: 99%

Acute Complications and Drug Misuse Are Important Causes of Death for Children and Young Adults With Type 1 Diabetes

Feltbower

Bodansky

Patterson³

et al. 2008

Diabetes Care

163

100

View full text Add to dashboard Cite

OBJECTIVE -To examine mortality rates and causes of death among subjects diagnosed with type 1 diabetes aged Յ29 years.RESEARCH DESIGN AND METHODS -Subjects with type 1 diabetes from a population-based register in Yorkshire, U.K., diagnosed between 1978 and 2004 were linked to the U.K. National Health Service Central Register for death notifications. Deaths were coded using ICD-9 (1979ICD-9 ( -2000 and ICD-10 (2001ICD-10 ( -2005. Standardized mortality ratios (SMRs) were calculated using expected numbers of deaths from U.K. mortality rates by cause of death and age at diagnosis.RESULTS -A total of 4,246 individuals were followed up, providing 50,471 person-years of follow-up. Mean follow-up length was 12.8 years for individuals aged 0 -14 years and 8.3 for those aged 15-29 years. Overall, 108 patients died, of whom 77 (71%) were male. A total of 74 (1.7/1,000 person-years) deaths occurred in inidividuals aged 0 -14 years and 34 (4.6/1,000 person-years) in those aged 15-29 years. The SMR was 4.7 (95% CI 3.8 -5.6) overall, similar for males and females, but higher for individuals aged 15-29 years (SMR 6.2 [95% CI 4.3-8.6]) compared with those aged 0 -14 years (4.2 [3.3-5.3]). The SMR rose with increasing disease duration. A total of 47 of 108 deaths (44%) occurred from diabetes complications, 32 of which were acute and 15 chronic. Twenty-two percent (n ϭ 24) of deaths were attributed to accidents or violence (SMR 2.1 [95% CI 1.4 -3.2]), including six suicides. Sixteen percent of all deaths were related to drug misuse (including insulin but excluding tobacco and alcohol) ]).CONCLUSIONS -Subjects with type 1 diabetes diagnosed under 30 years of age had a 4.7-fold excess mortality risk. Nearly half of the deaths were due to acute or chronic complications of diabetes. Drug misuse-related deaths may be an emerging trend in this population warranting further investigation. Diabetes Care 31:922-926, 2008

show abstract

“…A further analysis performed by the DCCT research group in 1996 found that, on average, people on intensive therapy, as compared with those on conventional therapy, would experience an additional 7.7 yr of sight, 5.8 yr free from end‐stage renal disease and 5.6 yr free from lower extremity amputation (25). In support of the cost‐effectiveness of intensive therapy, it has been estimated that the additional costs of moving to insulin pump therapy are minimal, given the potential benefits (26). Insulin pump therapy can provide an effective way to help ensure consistent glycaemic control in children and adolescents.…”

Section: Resultsmentioning

confidence: 99%

Chapter Four: Diabetes in children: socioeconomic aspects

2007

Pediatr Diabetes

View full text Add to dashboard Cite

Insulin pump therapy in childhood diabetes—cost implications for Primary Care Trusts

Abstract: The additional resources required to pay for insulin pump therapy for a small proportion of the diabetes population would be minimal given the potential benefits to these patients of improved control and anticipated reduction in long-term morbidity.

Cited by 14 publications

References 11 publications

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

Acute Complications and Drug Misuse Are Important Causes of Death for Children and Young Adults With Type 1 Diabetes

Chapter Four: Diabetes in children: socioeconomic aspects

Contact Info

Product

Resources

About